Clinical Trial Update: Risk-adapted Therapy for Adult Acute Myeloid Leukemia. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of risk-adapted therapy for adult acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias | Conditions: Leukemia, Myelocytic, Acute | Phase 2 | Status: COMPLETED